Plenty of money in the bank, numerous INDs and trials with near term inflection points, a recent acquisition for a similar company with arguably an inferior product... Hard not to like cu6.
not to mention 2 prvs
Ann: IND approval from the FDA for theranostic SAR-Bombesin trial, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.95 |
Change
0.210(3.66%) |
Mkt cap ! $1.864B | |||
| Open | High | Low | Value | Volume |
| $5.95 | $5.99 | $5.76 | $5.971M | 1.017M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 573 | $5.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.96 | 4656 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |